Skip main navigation

New offer! Get 30% off your first two months of Unlimited. Subscribe for just £35.99 £24.99. New subscribers only. T&Cs apply.

Find out more

End of Week 2

A summary of what has been discussed in week two and what learners have learnt.
End written in chalk on the pavement
© BSAC

Well done on reaching the end of Week 2! We hope you enjoyed it. You should now have gained an understanding of:

  • How vaccine safety is assessed and monitored

  • Specific safety concerns related to vaccine associated disease enhancement

  • The difference between vaccine efficacy and effectiveness and how these are measured

  • Why efficacy assessment of COVID-19 vaccines in Phase III studies is difficult

  • How COVID-19 controlled human infection model studies could accelerate vaccine development and concerns regarding their use

Next week, we will look at some case studies where vaccines have been used to control infectious disease outbreaks. We will also learn about the different candidates for a COVID-19 vaccine.

See you in week 3!

© BSAC
This article is from the free online

Vaccine Development: Finding a Vaccine for COVID-19 and Future Pandemics

Created by
FutureLearn - Learning For Life

Reach your personal and professional goals

Unlock access to hundreds of expert online courses and degrees from top universities and educators to gain accredited qualifications and professional CV-building certificates.

Join over 18 million learners to launch, switch or build upon your career, all at your own pace, across a wide range of topic areas.

Start Learning now